financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Maintains Hold Opinion On Shares Of Boston Properties, Inc.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Maintains Hold Opinion On Shares Of Boston Properties, Inc.
May 1, 2024 8:30 AM

11:10 AM EDT, 05/01/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We lower our target by $9 to $60, on a forward P/FFO of 8.5x our 2024 FFO estimate, in line with office REIT peers as BXP's high exposure to troubled office markets (e.g., Seattle, Washington D.C.) is partially offset by its class A office concentration. We trim our 2024 FFO estimate by $0.05 to $7.04 and cut 2025's by $0.06 to $7.29. BXP reported Q1 2024 FFO of $1.73 vs. $1.73, a penny consensus beat on revenues that were 3% above consensus. Same-store cash NOI fell 2.9% Y/Y as occupancy dropped 40 bps Y/Y to 88.2%. Occupancy showed improvement in Los Angeles (87.8%, +10 bps Y/Y), New York (88.0%, +80 bps), and Washington D.C. (90.4%, +170 bps), but dropped in Seattle (81.8%, -610 bps), San Francisco (83.4%, -500 bps), and Boston (90.4%, -120 bps). Net rents rose 9.6% with BXP leasing 893K square feet in Q1, down from 1.5msf in Q4. BXP generated $142M in proceeds from dispositions in Q1 while acquiring one property for $35M. Leverage rose to 7.8x vs. 7.4x Q/Q while interest coverage remained stable at 2.9x.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Keeps Buy Opinion On Shares Of Alnylam Pharmaceuticals, Inc.
Research Alert: CFRA Keeps Buy Opinion On Shares Of Alnylam Pharmaceuticals, Inc.
Jun 3, 2025
01:15 PM EDT, 06/03/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our target price to $343 from $321 based on our net present value analysis. We lift our 2025 EPS estimate to $0.69 from -$0.02, as we forecast improved...
Research Alert: CFRA Keeps Buy Opinion On Shares Of Hewlett Packard Enterprise Company
Research Alert: CFRA Keeps Buy Opinion On Shares Of Hewlett Packard Enterprise Company
Jun 4, 2025
10:55 AM EDT, 06/04/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We maintain our Buy rating and lift our 12-month target to $21 from $18, 9.5x our FY 26 EPS view, reflecting HPE's strong AI positioning despite execution challenges. We cut...
7 key quotes from investor Bill Ackman that could make you wealthier
7 key quotes from investor Bill Ackman that could make you wealthier
Jun 3, 2025
Bill Ackman is the billionaire investor behind the hedge fund Pershing Square Capital, and he's one of the most notable investors of the last two decades. Ackman typically bets big, with huge positions in stocks that are often momentarily out of favor or at least those where value has yet to be realized. Ackman often goes to the media to...
Research Alert: CFRA Lifts Opinion On Shares Of Dollar General Corporation To Hold From Sell
Research Alert: CFRA Lifts Opinion On Shares Of Dollar General Corporation To Hold From Sell
Jun 3, 2025
12:35 PM EDT, 06/03/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our 12-month target to $118 from $75, 18x our FY 27 (Jan.) EPS of $6.55 (up from $5.99; FY 26 up to $5.82 from $5.34). This valuation places...
Copyright 2023-2026 - www.financetom.com All Rights Reserved